| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.7M | +46.8% |
| Cost of Revenue | $729K | -68.6% |
| R&D Expense | $16.2M | -16.7% |
| SG&A Expense | $33.5M | +10.5% |
| Operating Income | -$60.1M | +5.4% |
| Pre-tax Income | -$101.7M | -42.2% |
| Income Tax | $173K | -21.7% |
| Net Income | -$101.9M | -42.0% |
| EPS (Basic) | -$0.84 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $40.8M | +931.5% |
| Accounts Receivable | $3.3M | +41.6% |
| Current Assets | $86.0M | -5.7% |
| Total Assets | $161.7M | -0.3% |
| Current Liabilities | $12.1M | +23.9% |
| Long-term Debt | $54.6M | +12.7% |
| Total Liabilities | $111.6M | +36.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$38.0M | -7.2% |
| Capital Expenditures | $350K | -87.3% |
| Investing Cash Flow | -$39.5M | -3774.8% |
| Financing Cash Flow | $35.1M | -49.1% |
| Free Cash Flow | -$38.4M | -0.4% |
| -27.3% |
| EPS (Diluted) | -$0.84 | -27.3% |
| Stockholders' Equity |
| $50.1M |
| -36.3% |